Now, even with my doctor's reminders, I still find myself staring at my plate without any urge to eat
FDA Access Data+1 In 2025, the FDA expanded Ozempics label to include reducing the risk of kidney disease progression and cardiovascular death in adults with type 2 diabetes and chronic kidney disease, based on the FLOW trial
Tahara N, Tahara A, Honda A, et al
Anyone considering switching from Tirzepatide to Retatrutide should take time to understand how each medication works, what side effects to anticipate, and what their dosing schedule will look like
The answer is mL
The dual agonist mechanism may provide metabolic benefits, though the precise contribution of GIP receptor activation to weight loss remains an area of ongoing research